Offer - Urjas Oil for just ₹ 1 X
Parcar is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Acromegaly, Prolactinoma.
Medical history of the patient along with age and gender determines the dosage of Parcar. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Parcar can also lead to other problems, which have been listed below. Such side effects of Parcar normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Parcar's effect is Mild during pregnancy and Severe for lactating mothers. Warnings related to Parcar's effects on the liver, heart and kidney, if any, have been listed below.
Parcar is not recommended if you suffer from certain medical conditions as it can have adverse effects. High Blood Pressure, Heart Disease, Depression are examples of such conditions. Some other conditions that can be affected by Parcar are listed in the contraindications section below.
Drug interactions for Parcar have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Parcar is not safe while driving, and is is not addictive in nature.
Parcar is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Parcar safe for pregnant women?
Pregnant women can consume [medicine]. Though Parcar has mild side effects when taken during pregnany
Is the use of Parcar safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Parcar. It should only be taken after medical advice.
What is the effect of Parcar on the Kidneys?
There can be some harmful effects on your kidneys after taking Parcar. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Parcar on the Liver?
Parcar can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Parcar on the Heart?
The heart can be affected by Parcar. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Parcar should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Parcar unless your doctor advises you to do so -
Is this Parcar habit forming or addictive?
Parcar is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Parcar, you should not drive or work on any heavy machine, as Parcar can make you drowsy.
Is it safe?
Yes, but take Parcar only as per medical advice.
Is it able to treat mental disorders?
No, Parcar cannot treat any kind of mental disorder.
Interaction between Food and Parcar
Information is not available on the interaction of any foods with Parcar, due to a lack of research on this.
Interaction between Alcohol and Parcar
Drinking alcohol while taking Parcar may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 239-240
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Dostinex® (cabergoline)